'Ivig' presentation slideshows

William Tarnow-Mordi Professor of Neonatal Medicine University of Sydney

1.49k views • 133 slides

IVIG Intravenous Immunoglobulin

IVIG Intravenous Immunoglobulin. Gabriela M a Claudia Tiago. IVIG ou IVIg Intravenous Immunoglobulin. IVIG is a blood product administered intravenously It contains the pooled Ig G extracted from the plasma of over one thousand blood donors

410 views • 38 slides

????????? ???????????????????????????? ???????????????????????????????

????????? ???????????????????????????? ???????????????????????????????. ???.????? ???????? ???.??????? ?????????. Problem list. Kawasaki disease with Coronary artery aneurysm. Kawasaki disease. First described in Japan in 1967 by Tomisaku Kawasaki An acute, self-limited vasculitis

592 views • 30 slides

Kawasaki Disease: An Update of diagnosis and treatment

Kawasaki Disease: An Update of diagnosis and treatment. What is Kawasaki Disease?. Idiopathic multisystem disease characterized by vasculitis of small & medium blood vessels, including coronary arteries. Diagnostic Criteria. Fever for at least 5 days At least 4 of the following 5 features:

552 views • 27 slides

Journal Club General Medicine C- 4/3/14

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Journal Club General Medicine C- 4/3/14. Background- Mx of KD. Treatment resistance

390 views • 22 slides

Intravenous Immunoglobulin Market Drivers, Size and Emerging Trends Forecast to 2025

IVIG marketplace is observing a robust development owing to growing figure of patients by way of hemorrhage sicknesses, growing elderly inhabitants and growing numeral of Chronic Inflammatory Demyelinating Polyneuropathy [CIDP] patients.

59 views • 5 slides

Intravenous Immunoglobulin Market Size | Industry Forecast By 2025

IVIG Market is projected to reach $15,964 million by 2025, at a CAGR of 7.5%. hypogammaglobulinemia segment has highest contributor

21 views • 2 slides